Injective is trading at $7.72, holding above all major moving averages while the majority of top traders on the exchange are positioned net long. According to market data, 58% of top traders are net long on the token, a sign that larger accounts are leaning bullish even as price consolidates below a stubborn resistance level.
The immediate technical hurdle sits at $7.84. A clean break above that level could open the door to the upper Bollinger Band at $8.62, with some chart watchers projecting that move could play out within seven to 10 days if momentum holds.
Where price sits on the chart
Injective's current price of $7.72 puts it above every major moving average — a configuration that typically signals the path of least resistance is still up. The token has managed to stay above those levels even as broader crypto markets have traded sideways, which keeps the short-term trend intact.
The $7.84 resistance isn't a random number. It's the level that has capped recent upside attempts, and it's the trigger point traders are watching. Until it breaks, the setup remains a wait-and-see for anyone looking for a fresh entry.
The upper Bollinger Band at $8.62 is the next real target. Bollinger Bands measure volatility around a moving average, and when price rides the upper band, it often means buyers are in control. That $8.62 area is where the band currently sits, making it a natural magnet if buying pressure picks up.
What the positioning data shows
The 58% net long reading among top traders is the kind of detail that gets attention because it reflects what larger, often more informed accounts are doing with real money. It's not a survey or a sentiment poll — it's actual positioning. When that group leans long while price holds above key averages, it suggests they're not expecting a breakdown.
That doesn't guarantee a rally. Positioning can flip fast, especially in a market where a single macro headline can wipe out a day's gains. But for now, the balance of evidence from the derivatives side tilts bullish.
The $7.84 trigger and the $8.62 target
If $7.84 gives way, the move to $8.62 could happen quickly. That's roughly an 11% gain from the current $7.72 price, and the seven-to-10-day window being discussed is based on how the Bollinger Band has behaved in similar setups. Volatility tends to expand once price breaks a well-defined resistance, and the upper band often acts as the first profit-taking zone.
The risk is a failed breakout. If $7.84 rejects price again, Injective could slip back toward its moving averages, and a break below those would weaken the bullish case. For now, though, the token is holding where it needs to hold.
What to watch next
The next few sessions matter. A daily close above $7.84 would be the first confirmation that buyers are serious. If that happens, all eyes shift to $8.62 and whether the upper band gets tested. On the flip side, losing the moving averages would put the net-long crowd on the defensive and likely force some of those positions to unwind.
Injective's price prediction chatter has centered on these two levels for days now. The data hasn't changed the script — it's still $7.84 first, then $8.62. Until one of those breaks, the market is in a holding pattern, and the 58% net-long positioning is the biggest clue about which way traders think it'll go.
